ACHIEVING IMPACT USING OCCUPATIONAL THERAPY IN EDUCATION, FOR MARGINALISED COMMUNITIES AND IN PUBLIC HEALTH
With
Associate Professor Emma George, Program Director, Occupational Therapy
School of Allied Health Science and Practice,
The University of Adelaide &
Board Director, Occupational Therapy Australia &
Australian Delegate, World Federation of Occupational Therapists
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Adelaide | June 2025
Associate Professor Emma George is a leader in occupational therapy, fascinated by the role and importance of occupation as a right for health and well-being. Her research projects all explore the way we address health inequities among marginalised people and communities with a commitment to social and occupational justice.
She has led and collaborated in research on national policy implementation, the health and well-being of Aboriginal and Torres Strait Islander people and communities, and the recovery from exploitation and modern slavery in Australia and India.
In all of her research she am committed to learning more about occupational injustices (marginalisation, alienation, deprivation, imbalance, apartheid and dysfunction), the recognition and realisation of rights, and the response of allied health in order to promote equity and justice, culturally safe practice and trauma informed care. She is an Occupational Therapy Australia board director and serves as the elected Australian delegate to the World Federation of Occupational Therapists.
Source: Supplied
-
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
-
Elevating Professional Standards in the Medtech and Pharmaceutical Sector
ARCS Australia Ltd, the peak body representing professionals in the MedTech and Pharmaceutical sector, this week announced a series of significant changes at its annual conference.
Dr Tim Boyle, CEO of ARCS Australia Ltd speaking to Australian Health Journal says, “These initiatives are central to strategy to build professionalism within the sector, increase capability and enhance the professional standing of its members.”
-
Cardiovascular Disease Risk Guidance and Calculator get long overdue update
Cardiovascular disease (CVD) is responsible for significant morbidity and premature mortality in Australia. Ischaemic heart disease was the leading cause of death in 2020 and cerebrovascular disease was the third most common cause of death.
As the first major update to Australian CVD risk assessment guidelines in over a decade, the 2023 Australian Guideline for assessing and managing cardiovascular disease risk and associated Aus CVD Risk Calculator reflect the latest evidence on assessing, communicating, and managing CVD risk. Developed using Australian-specific data and the latest evidence, it supersedes the 2012 Guidelines for the management of absolute cardiovascular disease risk.
